BOT 1.18% 42.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-163

  1. 4,670 Posts.
    lightbulb Created with Sketch. 717
    My very modest contribution [again] to this is.....no-one goes "into business" as it were, wanting just 1/2% of the market,......particularly, if you've got a new-generation product, as good/better and more user friendly for the customer....I'll leave it to the experienced BOT team to deliver, but they surely must see a minimum 15/20% market-share in this space within the next 4/5yrs or so.....and growing!

    This is a "purpose built" product for those with excessive sweating disorders and it's not injection delivered!

    They want and can achieve a "market-leading" position.....they [BOT m'ment] have the experience!

    Yeah the world could end, it could all fall-over etc etc, but they still want a market-share WELL NORTH of any single figure....well north!

    DYOR....just me thinking out loud.....but would you go into business, with a top-notch product and 6 star m'ment for gggoooollllyyyyyy "1%" of the market.....
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
-0.005(1.18%)
Mkt cap ! $761.8M
Open High Low Value Volume
43.0¢ 44.5¢ 41.5¢ $2.435M 5.697M

Buyers (Bids)

No. Vol. Price($)
20 819538 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 29052 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.